Validation of patient-reported global severity of atopic dermatitis in adults
| Autor: | Ryan Sacotte, Jonathan I. Silverberg, Supriya Immaneni, Robert Kantor, N. Patel, Derek Y. Hsu, Paras P. Vakharia, T. White, Rishi Chopra |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Concordance Immunology Severe disease Severity of Illness Index Dermatitis Atopic Young Adult 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Surveys and Questionnaires Epidemiology medicine Humans Immunology and Allergy Prospective Studies SCORAD Aged Aged 80 and over medicine.diagnostic_test business.industry Clinical course Reproducibility of Results Atopic dermatitis Middle Aged medicine.disease Dermatology Clinical Practice 030228 respiratory system Female Self Report business |
| Zdroj: | Allergy. 73:451-458 |
| ISSN: | 0105-4538 |
| DOI: | 10.1111/all.13309 |
| Popis: | Background Atopic dermatitis (AD) is associated with a heterogeneous presentation and clinical course. There is a lack of simple and validated severity assessments that are feasible for clinical practice and epidemiological research. Objectives We sought to validate patient-reported global AD severity in adults. Methods We performed a prospective dermatology practice-based study using questionnaires and evaluation by a dermatologist (n = 265). Results At baseline and follow-up, patient-reported global AD severity significantly correlated with oSCORAD (Spearman ρ = 0.56 and 0.49), SCORAD (0.64 and 0.56), EASI (0.56 and 0.50), BSA (0.52 and 0.45), NRS-itch (0.60 and 0.53), POEM (0.50 and 0.48), and DLQI (0.50 and 0.49) (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text